165 related articles for article (PubMed ID: 36969045)
21. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
22. UCHL-3 as a potential biomarker of ovarian cancer.
Yang Q; Peng X; Nian Z; Yuan S; Wang Z; Song Y; Shamsnur R; Wang H; Yi T
Gynecol Oncol; 2024 Mar; 182():156-167. PubMed ID: 38266402
[TBL] [Abstract][Full Text] [Related]
23. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
Ji P; Liang S; Li P; Xie C; Li J; Zhang K; Zheng X; Feng M; Li Q; Jiao H; Chi X; Zhao W; Zhang S; Wang X
Biochem Biophys Res Commun; 2018 Jul; 502(1):30-42. PubMed ID: 29777712
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.
Gao J; Ding F; Liu Q; Yao Y
Mol Cell Biochem; 2013 Apr; 376(1-2):21-32. PubMed ID: 23232575
[TBL] [Abstract][Full Text] [Related]
25. BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.
Han P; Fu Y; Luo M; He J; Liu J; Liao J; Tian D; Yan W
Dig Dis Sci; 2014 May; 59(5):992-1000. PubMed ID: 24442236
[TBL] [Abstract][Full Text] [Related]
26. PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells.
Guo J; Lan Z
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):37-45. PubMed ID: 31852247
[No Abstract] [Full Text] [Related]
27. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
[TBL] [Abstract][Full Text] [Related]
28. RPLP1 is highly expressed in hepatocellular carcinoma tissues and promotes proliferation, invasion and migration of human hepatocellular carcinoma Hep3b cells.
Xie C; Cao K; Peng D; Qin L
Exp Ther Med; 2021 Jul; 22(1):752. PubMed ID: 34035849
[TBL] [Abstract][Full Text] [Related]
29. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma.
Pan Y; Tong S; Cui R; Fan J; Liu C; Lin Y; Tang J; Xie H; Lin P; Zheng T; Yu X
Cell Physiol Biochem; 2018; 50(1):108-120. PubMed ID: 30278452
[TBL] [Abstract][Full Text] [Related]
30. RNF126 contributes to stem cell-like properties and metastasis in hepatocellular carcinoma through ubiquitination and degradation of LKB1.
Huang J; Li Y; Zheng M; He H; Xu D; Tian D
Hum Cell; 2022 Nov; 35(6):1869-1884. PubMed ID: 36068398
[TBL] [Abstract][Full Text] [Related]
31. Mechanical force induces macrophage-derived exosomal UCHL3 promoting bone marrow mesenchymal stem cell osteogenesis by targeting SMAD1.
Pu P; Wu S; Zhang K; Xu H; Guan J; Jin Z; Sun W; Zhang H; Yan B
J Nanobiotechnology; 2023 Mar; 21(1):88. PubMed ID: 36915132
[TBL] [Abstract][Full Text] [Related]
32. ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition.
Ye Z; Chen X; Chen X
Oncol Lett; 2018 Feb; 15(2):1511-1516. PubMed ID: 29434843
[TBL] [Abstract][Full Text] [Related]
33. Chondroitin polymerizing factor (CHPF) contributes to malignant proliferation and migration of hepatocellular carcinoma cells.
Xu Q; Lin W; Tao C; Huang X; Li J
Biochem Cell Biol; 2020 Jun; 98(3):362-369. PubMed ID: 32383983
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
35. [GPCR48 promotes invasion and metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma cells].
Peng QL; Wei SM; Zhang L; Gan LY; Xie Z; Qin J; Zhang Z; Wei JX
Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):849-854. PubMed ID: 34638203
[No Abstract] [Full Text] [Related]
36. Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma.
Zhang XF; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Wang DD; Jiang SS; Zheng HX; Lv L; Chen CL; Zhang HX; Xia JC
Mol Carcinog; 2016 Jan; 55(1):64-76. PubMed ID: 25557723
[TBL] [Abstract][Full Text] [Related]
37. Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis.
Zheng W; Yao M; Wu M; Yang J; Yao D; Wang L
J Transl Med; 2020 Feb; 18(1):81. PubMed ID: 32059741
[TBL] [Abstract][Full Text] [Related]
38. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
[TBL] [Abstract][Full Text] [Related]
39. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
[TBL] [Abstract][Full Text] [Related]
40. UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway.
Zhang MH; Zhang HH; Du XH; Gao J; Li C; Shi HR; Li SZ
Oncogene; 2020 Jan; 39(2):322-333. PubMed ID: 31477831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]